DEVA INSIGHTS & INDUSTRY NEWS

Tear-free is not a marketing adjective in a newborn care range. It is a formulation outcome. A tear-free 2-in-1 shampoo and body wash reaches that outcome through a narrower window than a single-use wash. A single-use wash optimises for one surface. A 2-in-1 cleans hair, cleans skin, and stays tolerable when lather reaches the eye. The eye then sets the limit for all three. This article covers where the extra difficulty comes from. It walks through the three surfaces one form

A tear-free surfactant system stands or falls on two families: glucosides and amino acid surfactants. Both sit in the mildest band used in infant and sensitive-skin cleansing. They differ on foam, pH, viscosity and cost. The glucoside vs amino acid surfactants choice decides how the finished wash lathers, how it thickens and what it costs per unit. This comparison covers the molecule, the blend architecture, the cost sheet and the eye irritation evidence that holds a tear-fre

A tear-free baby wash starts with the surfactant system, not with the fragrance or the bottle. Three families do most of the work in infant cleansers today. Glucosides bring mildness and a soft, stable foam. Amino acid surfactants bring a fine lather and a low irritation profile. Sulfosuccinates bring the lowest eye irritation of the three and the weakest foam. Each family carries its own cost and its own pH window. Choosing one on a supplier claim alone usually ends in a ref

A screening order fixes most of the sensitization risk in a baby formula before the first sample exists. Three ingredient families decide the outcome. Each acts through a different mechanism, so one ranking does not fit all three. Isothiazolinones and formaldehyde releasers sit at the top of the list. Phenoxyethanol, sodium benzoate and potassium sorbate sit at the bottom. Essential oils are not a safer route, because the same declarable allergens appear inside them. Surfacta

No ethics committee approves an induced sensitisation test on an infant. The human data behind a hypoallergenic baby skincare claim therefore comes from adults. Proof runs from raw materials to batch records. Ingredient screening removes known sensitisers first. In vitro assays then screen the formula as marketed. A 48-hour patch test measures irritation, and an HRIPT on at least 50 adults looks for delayed allergy. The file closes with the batch records that tie the tested f

Hypoallergenic is unregulated in the United States and only partly guided in the European Union. In both markets the word describes a manufacturer's intent, not a certified property. What the FDA says today The FDA states that no federal standards or definitions govern the use of the term. Manufacturers do not have to submit substantiation of a hypoallergenic claim. The agency tried to change that. It proposed a rule in 1974 and published a final version in 1975, which entere

Fragrance-free baby skincare has to clear two legal tests at once. The first is an accurate allergen declaration under Regulation (EC) No 1223/2009. The second is a claim you can prove under Commission Regulation (EU) No 655/2013. EU law does not ban fragrance in a product for a baby. It requires you to name the allergens above a threshold, and it controls what you may print on the pack. Since 31 July 2026 every new product placed on the EU market must carry the expanded alle

Two rules decide whether fragrance-free claims in baby skincare survive a market check. One governs the words on the pack. The other governs the molecules in the batch. A brand has to satisfy both, and the two duties live in different files. Commission Regulation (EU) No 655/2013 sets six common criteria for every cosmetic claim. Article 20 of Regulation (EC) No 1223/2009 forbids any text or image that gives a product properties it does not have. Regulators judge the claim ag

EU rules on fragrance allergens in baby skincare now name 81 substances for individual declaration. The list held 26 entries from 2005 until 2026. A baby lotion, wash or balm placed on the EU market from 31 July 2026 must carry every listed allergen above its threshold. The original list came through Directive 2003/15/EC. That act wrote the contact allergens from the SCCNFP opinion of 1999 into Annex III. It held 24 single chemicals and 2 moss extracts. Those were Evernia pru